Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;330:146 (15 January), doi:10.1136/bmj.330.7483.146-b
| The first 150 words of the full text of this article appear below. |
EDITORThe article by Pocock et al outlined deficiencies in epidemiological research.1 Undoubtedly, the deficiencies they reported will be generalised to all observational studies, even though they specifically excluded papers examining treatments or patients with diseases. Even the accompanying editorial revisits the hormone replacement therapy debacle.2 Interestingly, a paper about hormone replacement therapy would not have been eligible for this review as studies using pharmacological treatments were excluded. However, the authors dedicate only two paragraphs to the methods section so this fact may not be obvious at first glance, or not at all if the abstract is reviewed in isolation.
Before this study is used as another reason to discredit all observational research, its limitations should be appreciated. The authors say that clinical epidemiology in people with disease and studies in pharmacoepidemiology raise similar issues,1 but they provide no data to support this generalisation. On the basis of their
David F Blackburn, assistant professor
College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada S7N 5C9 d.blackburn@usask.ca